Table 2 Complication profile
| Â | Â | Aspirin | LMWH | P-value | |
|---|---|---|---|---|---|
Treatment | 458 (60.2%) | 303 (39.8%) | Â | ||
VTE | DVT | 3 (0.6%) | 4 (1.3%) | 0.72 | |
PTE | 1 (0.2%) | 0 | |||
Both | 1 (0.2%) | 1 (0.3%) | |||
Total | 5 (1.1%) | 5 (1.6%) | 0.53 | ||
Other Complications | Wound Discharge | 22 (4.8%) | 15 (4.9%) | 0.97 | |
Wound Infection | 14 (3.1%) | 7 (2.3%) | 0.65 | ||
Need for I&D | 5 (1.1%) | 6 (2.0%) | 0.36 | ||
Deep Knee Infection | 4 (0.9%) | 5 (1.6%) | 0.49 | ||
Swelling & Hemarthrosis | 19 (4.1%) | 11 (3.6%) | 0.85 | ||